Skip navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Results 1 - 10 of 13 for Speech therapy
  1. ... improve some symptoms. These treatments include physical and speech therapy and improving deficits in the immune system and ...
  2. ... refractory because they usually do not respond to therapy with anti-epileptic medications.Other signs and symptoms of CHD2 myoclonic encephalopathy include intellectual disability that ranges from mild to severe and delayed development of speech. Rarely, individuals can have a loss of acquired ...
  3. ... A. Pelizaeus-Merzbacher disease: cellular pathogenesis and pharmacologic therapy. Pediatr Int. 2014 Oct;56(5):659-66. ...
  4. ... as refractory because they do not respond to therapy with anti-epileptic medications.Other neurological problems that ... J. STXBP1 encephalopathies: Clinical spectrum, disease mechanisms, and therapeutic strategies. J Neurochem. 2021 Apr;157(2):165- ...
  5. ... deafness and retinitis pigmentosa): pathogenesis, molecular diagnosis and therapeutic approaches. Curr Opin Neurol. 2012 Feb;25(1): ...
  6. ... M, Lund TC. Aspartylglucosaminuria: Clinical Presentation and Potential Therapies. J Child Neurol. 2021 Apr;36(5):403- ...
  7. ... s disease: from pathology and genetics to potential therapies. Biochem J. 2008 Jun 1;412(2):191- ...
  8. ... Type A Niemann-Pick disease: possible endpoints for therapeutic trials. Neurology. 2006 Jan 24;66(2):228- ...
  9. ... typically becomes apparent during adolescence. Without hormone replacement therapy, affected individuals do not develop secondary sexual characteristics ...
  10. ... DC. Glut-1 deficiency syndrome: clinical, genetic, and therapeutic aspects. Ann Neurol. 2005 Jan;57(1):111- ...
previous · 1 · 2 · next